首页> 外文期刊>Toxins >Bavachinin Induces Oxidative Damage in HepaRG Cells through p38/JNK MAPK Pathways
【24h】

Bavachinin Induces Oxidative Damage in HepaRG Cells through p38/JNK MAPK Pathways

机译:Bavachinin通过p38 / JNK MAPK途径诱导HepaRG细胞的氧化损伤

获取原文
           

摘要

Drug-induced liver injury is one of the main causes of drug non-approval and drug withdrawal by the Food and Drug Administration (FDA). Bavachinin (BVC) is a natural product derived from the fruit of the traditional Chinese herb Fructus Psoraleae (FP). There have been reports of acute liver injury following the administration of FP and its related proprietary medicines. To explore BVC hepatotoxicity and its mechanisms, we used the HepaRG cell line. In our recent research, we showed that BVC induces HepaRG cell death, mainly via BVC-induced oxidative damage. The formation of ROS is closely related to the activation of the stress-activated kinases, JNK and p38, while SP600125 (SP, JNK inhibitor) and SB203580 (SB, p38 inhibitor) pretreatment inhibited the generation of ROS. On the other hand, N-acetylcysteine (NAC) pretreatment prevented the phosphorylation of p38 but not that of JNK. Taken together, these data reveal that BVC induces HepaRG cell death via ROS and the JNK/p38 signaling pathways.
机译:药物引起的肝损伤是美国食品药品管理局(FDA)拒绝批准和停药的主要原因之一。 Bavachinin(BVC)是源自传统中草药F骨(FP)果实的天然产物。有报告称,服用FP及其相关专利药物后会导致急性肝损伤。为了探索BVC的肝毒性及其机制,我们使用了HepaRG细胞系。在我们最近的研究中,我们表明BVC主要通过BVC诱导的氧化损伤诱导HepaRG细胞死亡。 ROS的形成与应激激活激酶JNK和p38的激活密切相关,而SP600125(SP,JNK抑制剂)和SB203580(SB,p38抑制剂)预处理抑制了ROS的生成。另一方面,N-乙酰半胱氨酸(NAC)预处理阻止了p38的磷酸化,但阻止了JNK的磷酸化。综上所述,这些数据揭示了BVC通过ROS和JNK / p38信号通路诱导HepaRG细胞死亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号